An innovative stem cell therapy approved for severe heart failure has been cleared for use in Japan. Here is why it matters ...
Japan has approved two stem cell-based therapies for treating Parkinson's disease and heart failure in a world first, through ...
Morning Overview on MSN
Japan approves world-first iPSC therapy for Parkinson’s disease
Japan’s health ministry has endorsed the first stem-cell therapy derived from induced pluripotent stem cells (iPSCs) for ...
Aspen Neuroscience’s autologous, personalised stem cell therapy is set for a pivotal trial after it showed improved "ON" and ...
PHILADELPHIA--(BUSINESS WIRE)--Accelerated Biosciences and Stemmatters are thrilled to announce their strategic partnership aimed at co-developing and co-marketing human induced pluripotent stem cells ...
Since 2008, Labroots has used its virtual events to connect a global network of scientists regarding the latest advancements in their fields. These virtual | Drug Discovery And Development ...
XCells Biotechnologies USA, Inc. ("iXCells"), a leading provider of human cell-based solutions and custom iPSC services, today announced the delivery of over 500 characterized induced pluripotent stem ...
Nina Bauer of FUJIFILM Cellular Dynamics shares insight on addressing challenges and supporting developers heading towards commercialization.
DUBLIN--(BUSINESS WIRE)--The "Induced Pluripotent Stem Cells Market" report has been added to ResearchAndMarkets.com's offering. The Induced Pluripotent Stem Cells Market was valued at USD 3.4 billion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results